SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Blog
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
EGFR
Journals
15
1
European journal of medicinal chemistry
2
Bioorganic chemistry
3
International journal of pharmaceutics
4
PeerJ
5
Bioorganic & medicinal chemistry letters
6
molecular biology reports
7
Journal of biomolecular structure & dynamics
8
Journal of medical virology
9
International wound journal
10
journal of materials chemistry b
11
Travel medicine and infectious disease
12
the international journal of oral & maxillofacial implants
13
molecular and cellular biology
14
current problems in cancer
15
The Lancet. Respiratory medicine
Research Groups
0
No Research Group Connected
Bibliographies
31
1
The heart of a hibernator: EGFR and MAPK signaling in cardiac muscle during the hibernation of thirteen-lined ground squirrels, .
2
Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo[1,5-c]quinazolines as potential EGFR inhibitors.
3
Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
4
pH-Responsive polyelectrolyte coated gadolinium oxide-doped mesoporous silica nanoparticles (GdO@MSNs) for synergistic drug delivery and magnetic resonance imaging enhancement.
5
Clinicopathological and immunohistochemical characteristics of breast cancer patients from Northeast India with special reference to triple negative breast cancer: A prospective study.
6
EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling.
7
Immediate Dental Implant Stabilization in a Canine Model Using a Novel Mineral-Organic Adhesive: 4-Month Results.
8
synthesis, molecular docking and biological evaluation of glycyrrhizin analogs as anticancer agents targeting egfr
9
a pilot study (swog s0429) of weekly cetuximab and chest radiotherapy for poor-risk stage iii non-small cell lung cancer
10
survival predictors in paraquat intoxification and role of immunosuppression
11
thyroid dysfunctions and renal status: implications in hyponatremia
12
association between cd47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
13
role of the expression level of nrf2 in predicting response of egfr-tkis in lung adenocarcinoma patients with egfr gene mutations
14
identification and characterization of egf receptor in individual exosomes by fluorescence-activated vesicle sorting
15
reversing egfr mediated immunoescape by targeted monoclonal antibody therapy
16
the association of daily activity levels and estimated kidney function in men and women with predialysis chronic kidney disease
17
universal insertion/deletion-enrich pcr
18
non-small cell carcinoma biomarker testing: the pathologist's perspective.
19
induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice
20
new developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
21
folliculin interacts with rab35 to regulate egf-induced egfr degradation
22
response to her2 inhibition in a patient with brain metastasis with egfr tki acquired resistance and an her2 amplification
23
estimated glomerular filtration rate (egfr): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice
24
an immunohistochemical study of egfr expression in colorectal cancer and its correlation with lymph nodes status and tumor grade
25
mechanisms of activation of receptor tyrosine kinases: monomers or dimers
26
Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines.
27
Omicron N501Y mutation among SARS-CoV-2 lineages: In-silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine.
28
Omicron variant and booster COVID-19 vaccines.
29
Another year another variant: COVID 3.0-Omicron.
30
SARS-CoV-2 Omicron Variant: Could it be Another Threat?
31
Exploring the potential of biologically active phenolic acids from marine natural products as anticancer agents targeting the epidermal growth factor receptor.
×
SciMatic on Your Phone
Track your articles, view certificates, and stay updated — anywhere, anytime.
Google Play